Skip to main content
. 2011 Mar 7;11:9. doi: 10.1186/1471-2261-11-9

Table 2.

Association of six variants on 9p21.3: MI study population vs. controls

Variant Controls Risk Allele Frequency MI Cases n = 976 Risk Allele Frequency HW P value OR (95% CI)
rs1333040 b) n = 3532
C/C T/T T: 0.50 C/C T/T T: 0.56 0,993 <0.0001 1.621 (1.317-2.994)
893 889 181 292
rs10757274 c) n = 9053
A/A G/G G: 0.45 A/A G/G G: 0.52 0,075 <0.0001 1.904 (1.570-2.309)
2752 1758 208 253
rs2383206 c) n = 9053
A/A G/G G: 0.47 A/A G/G G: 0.55 0,06 <0.0001 1.867 (1.535-2.272)
2489 1981 183 272
rs2383207 b) n = 3532
A/A G/G G: 0.46 A/A G/G G: 0.55 0,25 <0.0001 2.039 (1.654-2.514)
1016 746 183 274
rs10757278 b) n = 718
A/A G/G G: 0.43 A/A G/G G: 0.52 0,062 <0.0001 1.941 (1.458-2.583)
224 128 211 243
rs1333049 a) n = 999
G/G C/C C: 0.46 G/G C/C C: 0.52 0,233 <0.0001 1.653 (1.280-2.135)
292 205 212 246

Genotype distribution and allelic frequencies of the investigated SNPs on 9p21.3 of the overall study cohort were compared with control data of the PopGen cohort (a) [11], the Iceland B collective (b) [4] or the Copenhagen City Heart Study (c) [3]. HW: P value for Hardy-Weinberg equilibrium test. P values and Odds ratios (OR) were calculated for the high-risk homozygous alleles.